Contrast-enhanced cardiac magnetic resonance in the evaluation of myocardial infarction and myocardial viability in patients with ischemic heart disease

Current Problems in Cardiology

Volumn 31, Issue 2, 2006, Pages 128-168

  Bucciarelli Ducci, Chiara ^a,b   Wu, Edwin ^a,c   Lee, Daniel C ^a   Holly, Thomas A ^a,c   Klocke, Francis J ^a,d   Bonow, Robert O ^a,c,e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^d Northwestern Memorial Hospital ^*

^e Bluhm Cardiovascular Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; GADOLINIUM; GADOLINIUM CHELATE; GADOLINIUM PENTETATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; THALLIUM 201; TRIPHENYLTETRAZOLIUM;

ANGIOPLASTY; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; DIFFERENTIAL DIAGNOSIS; FIBRINOLYTIC THERAPY; HEART AMYLOIDOSIS; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; META ANALYSIS; MYOCARDIAL HIBERNATION; MYOCARDITIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; REVIEW; SARCOIDOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; STUNNED HEART MUSCLE; SYSTEMATIC REVIEW;

EID: 30644467756     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpcardiol.2005.10.002     Document Type: Article

References (89)

1. M. Emond, M.B. Mock, K.B. Davis Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry Circulation 90 1994 2645-57.0
2. L.H. Muhlbaier, D.B. Pryor, J.S. Rankin Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease 20 years of follow-up Circulation 86 suppl II 1992 II-198-204
3. E.L. Alderman, P. Fischer, G.C. Litwin Results of coronary artery surgery in patients with poor left ventricular function (CASS) Circulation 68 1983 785 795
4. S.H. Rahimtoola Coronary bypass surgery for chronic angina - 1981 a perspective Circulation 65 1982 225 241
5. E. Braunwald, J. Rutherford Reversible ischemic left ventricular dysfunction evidence of the "hibernating myocardium" J Am Coll Cardiol 8 1986 1467 1470
6. S.H. Rahimtoola The hibernating myocardium Am Heart J 117 1989 211 213
7. V. Dilsizian, R.O. Bonow Current diagnostic techniques of assessing myocardial viability in hibernating and stunned myocardium Circulation 87 1993 1 20
8. G. Heusch, R. Schulz, S.H. Rahimtoola Myocardial hibernation a delicate balance Am J Physiol Heart Circ Physiol 288 2005 H984 H999
9. R.O. Bonow Identification of viable myocardium Circulation 94 1996 2674 2680
10. K.C. Allman, L.J. Shaw, R. Hachamovitch Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction a meta-analysis J Am Coll Cardiol 39 2002 1151 1158
11. R.O. Bonow Myocardial viability and prognosis in patients with ischemic left ventricular dysfunction J Am Coll Cardiol 39 2002 1159 1162
12. K.L. Gould Myocardial viability What does it mean and how to measure it? Circulation 83 1991 333 335
13. W. Rehwald, D.S. Fieno, E.L. Chen Myocardial magnetic resonance imaging contrast agent concentration after reversible and irreversible ischemic injury Circulation 105 2002 224 229
14. R.J. Kim, K.M. Choi, R.M. Judd Assessment of myocardial viability by contrast enhancement C.B. Higgins A. De Roos Cardiovascular MRI and MRA 2003 Lippincott Williams & Wilkins Philadelphia, PA 209 237
15. R.C. Brasch, H.J. Weinmann, G.E. Wesbey Contrast-enhanced NMR imaging animal studies using gadolinium-DTPA complex AJR Am J Roentgenol 142 1984 625 630
16. M. Saeed, G. Lund, M.F. Wendland Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media Circulation 103 2001 871 876
17. R.J. Kim, D.S. Fieno, T.B. Parrish Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile dysfunction Circulation 100 1999 1992 2002
18. R.J. Kim, E.L. Chen, J.A.C. Lima Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction Circulation 94 1996 3318 3326
19. L.C. Amado, B.L. Gerber, S.N. Gupta Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model J Am Coll Cardiol 44 2004 2383 2389
20. K.M. Choi, R.J. Kim, G. Gubernikoff Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function Circulation 104 2001 1101 1107
21. W.J. Rogers Jr, C.M. Kramer, G. Geskin Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction Circulation. 99 1999 744 750
22. C.M. Kramer, W.J. Rogers Jr, S. Mankad Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction J Am Coll Cardiol 36 2000 1835 1840
23. O.P. Simonetti, R.J. Kim, D.S. Fieno An improved MR imaging technique for the visualization of myocardial infarction Radiology 18 2001 215 223
24. J.N. Oshinski, Z. Yang, J.R. Jones Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging Circulation 104 2001 2838 2842
25. H. Mahrholdt, A. Wagner, T.A. Holly Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging Circulation 106 2002 2322 2327
26. R.M. Judd, R.J. Kim Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging Circulation 106 2002 e6
27. R.J. Kim, E. Wu, A. Rafael The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 2000 1445 1453
28. H.B. Hillenbrand, R.J. Kim, M.A. Parker Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging Circulation 102 2000 1678 1683
29. M.D. Cerqueira, N.J. Weissman, V. Dilsizian Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 2002 539 542
30. M.J. Budoff, M.C. Cohen, M.J. Garcia ACCF/AHA clinical competency statement on cardiac imaging with computed tomography and magnetic resonance J Am Coll Cardiol 46 2005 383 402
31. A.N. Lieberman, J.L. Weiss, B.I. Jugdutt Two-dimensional echocardiography and infarct size relationship of regional wall motion and thickening to the extent of myocardial infarction in the dog Circulation 4 1981 739 746
32. T. Force, A. Kemper, L. Perkins Overestimation of infarct size by quantitative two-dimensional echocardiography the role of tethering and of analytical procedures Circulation 73 1986 1360 1368
33. K. Sakai, K. Watanabe, R.W. Millard Defining the mechanical border zone a study in the pig heart Am J Physiol 249 1985 H88 H94
34. J.L. Weiss, B.H. Bulkley, G.M. Hutchins Two dimensional echocardiography recognition of myocardial injury in man comparison with postmortem studies Circulation 63 1981 401 408
35. J.H. Myers, M.C. Stirling, M. Choy Direct measurement of inner and outer wall thickening dynamics with epicardial echocardiography Circulation 74 1986 164 172
36. D.C. Homans, T. Pavek, D.D. Laxson Recovery of transmural and subepicardial wall thickening after subendocardial infarction J Am Coll Cardiol 24 1994 1109 1116
37. H. Mahrholdt, A. Wagner, M. Parker Relationship of contractile dysfunction to transmural extent of infarction in patients with chronic coronary artery disease J Am Coll Cardiol 42 2003 505 512
38. R.J. Gibbons, T.D. Miller, T.F. Christian Infarct size measured by single photon emission computed tomographic images with (99m)Tc-sestamibi a measure of the efficacy of therapy in acute myocardial infarction Circulation 101 2000 101 108
39. R.J. Gibbons, U.S. Valeti, P.A. Araoz The quantification of infarct size J Am Coll Cardiol 44 2004 1533 1542
40. K. Kitagawa, H. Sakuma, T. Hirano Acute myocardial infarction: myocardial viability assessment in patients early thereafter comparison of constrast-enhanced MR imaging with resting (201)Tl SPECT. Single photon emission computed tomography Radiology 226 2003 138 144
41. C. Klein, S.G. Nekolla, F.M. Bengel Assessment of myocardial viability with contrast-enhance magnetic resonance imaging comparison with positron emission tomography Circulation 105 2002 162 167
42. A. Wagner, H. Mahrholdt, T.A. Holly Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts an imaging study Lancet 361 2003 374 379
43. E. Wu, R.M. Judd, J.D. Vargas Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction Lancet 357 2001 21 28
44. J.C.C. Moon, Perez De Arenaza, A.G. Elkington The pathophysiological basis of Q-wave and non-Q wave myocardial infarction J Am Coll Cardiol 44 2004 554 560
45. A.E. Arai, G.A. Hirsch Q-wave and non-Q-wave myocardial infarction through the eyes of magnetic resonance imaging J Am Coll Cardiol 44 2004 561 563
46. H. Yang, M. Pu, D. Rodriguez Ischemic and viable myocardium in patients with non-Q-wave or Q-wave myocardial infarction and left ventricular dysfunction a clinical study using positron emission tomography, echocardiography, and electrocardiography J Am Coll Cardiol 43 2004 592 598
47. W.P. Ingkanisorn, K.L. Rhoads, A.H. Aletras Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction J Am Coll Cardiol 43 2004 2253 2259
48. D. Bello, D.S. Fieno, R.J. Kim Infarct morphology identifies patients with substrate for sustained ventricular tachycardia J Am Coll Cardiol 45 2005 1104 1108
49. F. Fedele, T. Montesano, M. Ferro-Luzzi Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction role of magnetic resonance imaging Am J Cardiol 128 1994 484 489
50. K. Ramani, R.M. Judd, T.A. Holly Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction Circulation 98 1998 2687 2694
51. D.S. Fieno, R.J. Kim, E.L. Chen Contrast-enhanced magnetic resonance imaging of myocardium at risk Distinction between reversible and irreversible injury throughout infarct healing J Am Coll Cardiol 36 2000 1985 1991
52. J.B. Selvanayagam, A. Kardos, J.M. Francis Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization Circulation 110 2004 1535 1541
53. J.J. Bax, F.C. Visser, D. Poldermans Time course of functional recovery of stunned and hibernating segments after surgical revascularization Circulation 104 2001 314 318
54. D. Bello, D.J. Shah, G.M. Farah Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing β-blocker therapy Circulation 108 2003 1945 1953
55. C.L. Grines, K.F. Browne, J. Marco A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction N Engl J Med 328 1993 673 679
56. R.A. Kloner, C.E. Ganote, R.B. Jennings The "no-reflow" phenomenon after temporary coronary occlusion in the dog J Clin Invest 54 1974 1496 1508
57. R.A. Kloner, W. Dai Glycoprotein IIb/IIIa inhibitors and no-reflow J Am Coll Cardiol 43 2004 284 286
58. R.M. Judd, C.H. Lugo-Olivieri, M. Arai Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of a 2-day-old reperfused canine infarcts Circulation 92 1995 1902 1910
59. C.E. Rochitte, J.A.C. Lima, D.A. Bluemke Magnitude and time course of microvascular obstruction and tissue injury after myocardial infarction Circulation 98 1998 1006 1014
60. K.C. Wu, E.A. Zerhouni, R.M. Judd Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction Circulation 97 1998 765 772
61. C. Bucciarelli-Ducci, E. Wu, P. Tejedor Hypoenhancement on delayed contrast-enhanced MRI following ST-segment elevation myocardial infarction an alternate approach for evaluating no-reflow J Cardiovasc Magn Res 7 2005 148 [Abstract]
62. V. Hombach, O. Grebe, N. Merkle Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging Eur Heart J 26 2005 549 566
63. G. Ambrosio, H.F. Weisman, J.A. Mannisi Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow Circulation 80 1989 1846 1861
64. J.U. Schlegel Demonstration of blood vessels and lymphatics with a fluorescent dye in ultraviolet light Anat Rec 105 1949 433 453
65. C.E. Rochitte, R.J. Kim, H.B. Hillebrand Microvascular integrity and the time course of myocardial sodium accumulation after acute infarction Circ Res 87 2000 648 655
66. The Multicenter Postinfarction Research Group Risk stratification and survival after myocardial infarction N Engl J Med 309 1983 331 336
67. A. Volpi, C. De Vita, M.G. Franzosi Determinants of 6-months mortality in survivors of myocardial infarction after thrombolysis results of the GISSI-2 data base Circulation 88 1993 416 429
68. H. Ito, T. Tomooka, N. Sakai Lack of myocardial perfusion immediately after successful thrombolysis Circulation 85 1992 1699 1705
69. H. Ito, A. Maruyama, K. Iwakura Clinical implication of the 'no-reflow' phenomenon a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction Circulation 93 1996 223 228
70. E. Wu, P. Tejedor, D.C. Lee No reflow detected by delayed contrast enhancment predicts remodeling following an ST-segment myocardial infarction Circulation 110 2004 III-444 [abstract]
71. B.L. Gerber, C.E. Rochitte, J.A. Melin Microvascular obstruction and left ventricular remodelling early after acute myocardial infarction Circulation 101 2000 2734 2741
72. M.C. Fishbein, J. Y-Rit, U. Lando The relationship of vascular injury and myocardial hemorrhage to necrosis alter reperfusion Circulation 62 1980 1274 1279
73. T. Reffelmann, S.L. Hale, J.S. Dow No-reflow phenomenon persists long term after ischemia/reperfusion in the rat and predicts infarct expansion Circulation 108 2003 2911 2917
74. L.C. Amado, D.L. Kraitchman, B.L. Gerber Reduction of "no-reflow" phenomenon by intra-aortic balloon conuterpulsation in a randomized magnetic resonance imaging experimental study J Am Coll Cardiol 43 2004 1291 1298
75. M.A. Pfeffer Left ventricular remodeling after acute myocardial infarction Ann Rev Med 46 1995 455 466
76. V. Richard, C.E. Murry, K.A. Reimer Healing of myocardial infarcts in dogs Effects of late reperfusion Circulation 92 1995 1891 1901
77. K.A. Reimer, J.E. Lowe, M.M. Rasmussen, R.B. Jennings The wavefront phenomenon of ischemic cell death Myocardial infarct size vs duration of coronary occlusion in dogs Circulation 56 1977 786 794
78. K.A. Reimer, R.B. Jennings The changing anatomic reference base of evolving myocardial infarction Underestimation of myocardial collateral blood flow and overestimation of experimental anatomic infarct size due to tissue edema, hemorrhage and acute inflammation Circulation 60 1979 866 876
79. D.S. Fieno, H.B. Hillebrand, W.G. Rehwald Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size J Am Coll Cardiol 43 2004 2124 2131
80. K.A. Reimer, R.B. Jennings The "wavefront phenomenon" of myocardial ischemic cell death, II transmural progression of necrosis within the framework of ischemic bed size (myocardial at risk) and collateral flow Lab Invest 40 1979 633 644
81. K.A. Reimer, J.E. Lowe, M.M. Rasmussen The "wavefront phenomenon" of ischemic cell death, I myocardial infarct size vs duration of coronary occlusion in dogs Circulation 56 1977 786 794
82. J.A. McCrohon, J.C.C. Moon, S.K. Prasad Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance Circulation 108 2003 54 59
83. W.C. Roberts, R.J. Siegel, B.M. McManus Idiopathic dilated cardiomyopathy analysis of 152 necropsy patients Am J Cardiol 60 1987 1340 1355
84. L. Choudhury, H. Mahrholdt, A. Wagner Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy J Am Coll Cardiol 40 2002 2156 2164
85. A.M. Maceira, J. Joshi, S.K. Prasad Cardiovascular magnetic resonance in cardiac amyloidosis Circulation 111 2005 186 193
86. J.C. Moon, B. Sachdev, A.G. Elkington Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease evidence for a disease specific abnormality of the myocardial interstitium Eur Heart J 24 2003 2151 2155
87. J.C. Moon, H.R. Mundy, P.J. Lee Myocardial fibrosis in glycogen storage disease type 3 Circulation 107 2003 e47
88. H. Mahrholdt, C. Goedecke, A. Wagner Cardiovascular magnetic resonance assessment of human myocarditis a comparison to histology and molecular pathology Circulation 109 2004 1250 1258
89. O. Vignaux Cardiac sarcoidosis spectrum of MRI features AJR Am J Roentgenol 184 2005 249 254